José Luís Calleja

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

María Reig, Zoe Mariñó, Christie Perelló et al. · Journal of Hepatology · 2016 · 1K citations

Hepatology, Hepatitis C, Hcv-related Hcc +12

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Càndid Villanueva, Agustı́n Albillos, Joan Genescà et al. · The Lancet · 2019 · 638 citations

Hypertension, Hepatology, Antihypertensive Therapy +8

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 518 citations

Hepatitis D, Hepatology, Viral Hepatitis +12

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text